MX2017010872A - Composiciones que comprenden combinaciones de cannabinoides purificados, con al menos uno de flavonoides, terpenos o minerales. - Google Patents

Composiciones que comprenden combinaciones de cannabinoides purificados, con al menos uno de flavonoides, terpenos o minerales.

Info

Publication number
MX2017010872A
MX2017010872A MX2017010872A MX2017010872A MX2017010872A MX 2017010872 A MX2017010872 A MX 2017010872A MX 2017010872 A MX2017010872 A MX 2017010872A MX 2017010872 A MX2017010872 A MX 2017010872A MX 2017010872 A MX2017010872 A MX 2017010872A
Authority
MX
Mexico
Prior art keywords
compositions
purified
flavonoid
combinations
terpene
Prior art date
Application number
MX2017010872A
Other languages
English (en)
Inventor
Aron Levy Kurt
Michael Cooper Jonathan
Original Assignee
Ebbu Llc
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Ebbu Llc filed Critical Ebbu Llc
Publication of MX2017010872A publication Critical patent/MX2017010872A/es

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K36/00—Medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicines
    • A61K36/18—Magnoliophyta (angiosperms)
    • A61K36/185—Magnoliopsida (dicotyledons)
    • A61K36/348—Cannabaceae
    • A61K36/3482—Cannabis
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/01—Hydrocarbons
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/01—Hydrocarbons
    • A61K31/015—Hydrocarbons carbocyclic
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/045—Hydroxy compounds, e.g. alcohols; Salts thereof, e.g. alcoholates
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/12—Ketones
    • A61K31/122—Ketones having the oxygen directly attached to a ring, e.g. quinones, vitamin K1, anthralin
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/335—Heterocyclic compounds having oxygen as the only ring hetero atom, e.g. fungichromin
    • A61K31/35—Heterocyclic compounds having oxygen as the only ring hetero atom, e.g. fungichromin having six-membered rings with one oxygen as the only ring hetero atom
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/335—Heterocyclic compounds having oxygen as the only ring hetero atom, e.g. fungichromin
    • A61K31/35—Heterocyclic compounds having oxygen as the only ring hetero atom, e.g. fungichromin having six-membered rings with one oxygen as the only ring hetero atom
    • A61K31/352—Heterocyclic compounds having oxygen as the only ring hetero atom, e.g. fungichromin having six-membered rings with one oxygen as the only ring hetero atom condensed with carbocyclic rings, e.g. methantheline 
    • A61K31/353—3,4-Dihydrobenzopyrans, e.g. chroman, catechin
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/658—Medicinal preparations containing organic active ingredients o-phenolic cannabinoids, e.g. cannabidiol, cannabigerolic acid, cannabichromene or tetrahydrocannabinol
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K33/00—Medicinal preparations containing inorganic active ingredients
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K2300/00—Mixtures or combinations of active ingredients, wherein at least one active ingredient is fully defined in groups A61K31/00 - A61K41/00

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Epidemiology (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Chemical & Material Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Natural Medicines & Medicinal Plants (AREA)
  • Botany (AREA)
  • Engineering & Computer Science (AREA)
  • Alternative & Traditional Medicine (AREA)
  • Biotechnology (AREA)
  • Medical Informatics (AREA)
  • Microbiology (AREA)
  • Mycology (AREA)
  • Inorganic Chemistry (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Medicinal Preparation (AREA)

Abstract

Se describen en la presente composiciones nuevas que tienen combinaciones de cannabinoides purificados. Una modalidad de la descripción proporciona composiciones que tienen uno o más cannabinoides purificados en composiciones con un terpeno purificado. Una modalidad de la descripción proporciona composiciones que tienen uno o más cannabinoides purificados en composiciones con un flavonoide purificado. Una modalidad de la descripción proporciona composiciones que tienen uno o más cannabinoides purificados en composiciones con un mineral purificado.
MX2017010872A 2015-02-27 2016-02-26 Composiciones que comprenden combinaciones de cannabinoides purificados, con al menos uno de flavonoides, terpenos o minerales. MX2017010872A (es)

Applications Claiming Priority (3)

Application Number Priority Date Filing Date Title
US201562126365P 2015-02-27 2015-02-27
US15/055,499 US20160250270A1 (en) 2015-02-27 2016-02-26 Compositions comprising combinations of purified cannabinoids, with at least one flavonoid, terpene, or mineral
PCT/US2016/019979 WO2016138505A1 (en) 2015-02-27 2016-02-26 Compositions comprising combinations of purified cannabinoids, with at least one flavonoid, terpene, or mineral

Publications (1)

Publication Number Publication Date
MX2017010872A true MX2017010872A (es) 2018-05-07

Family

ID=56789971

Family Applications (1)

Application Number Title Priority Date Filing Date
MX2017010872A MX2017010872A (es) 2015-02-27 2016-02-26 Composiciones que comprenden combinaciones de cannabinoides purificados, con al menos uno de flavonoides, terpenos o minerales.

Country Status (7)

Country Link
US (2) US20160250270A1 (es)
AU (1) AU2016225026A1 (es)
BR (1) BR112017018316A2 (es)
CA (1) CA2977802A1 (es)
IL (1) IL254025B (es)
MX (1) MX2017010872A (es)
WO (1) WO2016138505A1 (es)

Families Citing this family (74)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US20160250270A1 (en) 2015-02-27 2016-09-01 Ebbu, LLC Compositions comprising combinations of purified cannabinoids, with at least one flavonoid, terpene, or mineral
PT3429580T (pt) * 2016-03-16 2025-08-12 Buzzelet Development And Technologies Ltd Composição de canabinoides enriquecida em terpenos
EP3443496A1 (en) 2016-04-11 2019-02-20 Altopa, Inc. Secure portable, on-demand, microfluidic mixing and dispensing device
US10588974B2 (en) 2016-04-22 2020-03-17 Receptor Holdings, Inc. Fast-acting plant-based medicinal compounds and nutritional supplements
EP3468530A4 (en) 2016-06-10 2020-03-11 Clarity Cosmetics Inc. NON-COMEDOGEN FORMULA FOR HAIR AND SCALP CARE AND METHOD FOR USE
KR20190035791A (ko) 2016-08-03 2019-04-03 젤다 테라퓨틱스 오퍼레이션즈 피티와이 엘티디 카나비스 조성물
CA3034004C (en) 2016-08-29 2021-08-03 Canopy Growth Corporation Water soluble compositions comprising purified cannabinoids
US12485129B2 (en) 2016-08-29 2025-12-02 Canopy Growth Corporation Water soluble compositions comprising purified cannabinoids
CN109963595B (zh) 2016-10-11 2023-02-03 Gbs全球生物制药公司 用于治疗神经退行性疾病的含有大麻素的复合混合物
CA3044676A1 (en) * 2016-12-01 2018-06-07 Natural Extraction Systems, LLC Rapid botanical oil distillation device utilizing microwave agent
EA201892396A1 (ru) 2016-12-02 2019-04-30 Ресептор Лайф Сайенсиз, Инк. Быстродействующие растительные лекарственные соединения и биологически активные добавки
US10239808B1 (en) 2016-12-07 2019-03-26 Canopy Holdings, LLC Cannabis extracts
WO2018118197A1 (en) * 2016-12-21 2018-06-28 Richard Postrel Healthier aging in domesticated animals
USD802992S1 (en) 2017-01-16 2017-11-21 Altopa, Inc. Blend machine
WO2018144637A1 (en) * 2017-02-01 2018-08-09 Growblox Life Sciences L.L.C. Cannabinoid-containing complex mixtures for the treatment of mast cell-associated or basophil-mediated inflammatory disorders
JP6847520B2 (ja) * 2017-02-03 2021-03-24 長谷川香料株式会社 テルペン系炭化水素香料化合物高含有の水中油型乳化香料組成物
US11974984B2 (en) 2017-02-09 2024-05-07 Caamtech, Inc. Compositions and methods comprising a combination of serotonergic drugs
US12414936B2 (en) 2017-02-09 2025-09-16 Caamtech, Inc. Compositions comprising a serotonergic tryptamine compound
AU2018227544A1 (en) * 2017-03-01 2019-08-29 Canopy Growth Corporation Compositions purposefully selected comprising purified cannabinoids and/or purified terpenes
EA201992247A1 (ru) * 2017-03-23 2020-03-24 Ресептор Холдингз, Инк. Быстрая и контролируемая доставка композиций с восстановленным эффектом антуража
MX2019011510A (es) * 2017-03-30 2020-01-09 Ojai Energetics Pbc Metodos y composiciones para mejorar la salud.
CN110913839A (zh) * 2017-05-22 2020-03-24 Gbs全球生物制药公司 靶向trpv1的含月桂烯和大麻素的组合物
CA3065167A1 (en) * 2017-05-31 2018-12-06 Phytecs, Inc. Pharmaceutical compositions comprising cannabidiol and beta-caryophyllene and methods for their use
US20180344786A1 (en) * 2017-06-06 2018-12-06 NC3 Systems System and method enhanced cannabiniod effect delivery
US10172897B2 (en) 2017-06-06 2019-01-08 Cmg Partners, Inc. Enhanced smokable therapeutic cannabis product and method for making same
US10206888B2 (en) 2017-06-06 2019-02-19 Cmg Partners, Inc. Cannabis-based therapeutic product for treatment of chronic pain
AU2018286647B2 (en) 2017-06-19 2024-03-28 Zelira Therapeutics Operations Pty Ltd Sleep disorder compositions and treatments thereof
USD873068S1 (en) 2017-07-16 2020-01-21 Altopa, Inc. Blend device
WO2019067769A1 (en) 2017-09-28 2019-04-04 Canopy Growth Corporation COMPOSITIONS OF EDIBLE CANNABINOIDS
WO2019074951A1 (en) 2017-10-09 2019-04-18 Altopa, Inc. SECURED, ON-DEMAND PORTABLE MICROFLUIDIC DEVICE FOR MIXING AND DISPENSING MIXTURES OF LIQUIDS, SOLUTIONS, SUSPENSIONS, EMULSIONS AND COLLOIDS
EP3703672A4 (en) * 2017-10-30 2021-12-01 Endocanna Health, Inc. CANNABINOID FORMULATIONS
US11116210B2 (en) * 2017-11-10 2021-09-14 American River Nutrition, Llc Annatto extracts for insect repellency, larvicidal activity and methods of use
CN109985042A (zh) 2017-12-29 2019-07-09 汉义生物科技（北京）有限公司 一种含有大麻二酚或大麻提取物和咖啡因的组合物及其应用
US12458906B2 (en) 2018-01-23 2025-11-04 High Sierra Technologies, Inc. Methods of modifying a naturally occurring cannabis raw plant material, a purified cannabis product from a naturally occurring cannabis raw plant material, and a modified cannabis product from a naturally occurring cannabis raw plant material
WO2019147690A1 (en) 2018-01-23 2019-08-01 High Sierra Technologies, Inc. Cannabis products modified by removing volatile organic compounds and adding volatile unsaturated hydrocarbons
CA3089994A1 (en) 2018-01-31 2019-08-08 Canopy Holdings, LLC Hemp powder
WO2019159176A1 (en) * 2018-02-18 2019-08-22 Scicann Therapeutics Inc. Compositions and methods for treatment of neurodegenerative diseases
JP2021516210A (ja) * 2018-03-12 2021-07-01 ボミ リミテッド ライアビリティ カンパニー フムルス植物の変種およびその抽出物
WO2019191830A1 (en) 2018-04-04 2019-10-10 Vincenzo Maida Topical cannabinoid formulations and instillates, kits, and methods for treating integumentary wounds, and uses thereof
WO2019200224A1 (en) * 2018-04-13 2019-10-17 The Broad Institute, Inc. Synergistic drug combinations predicted from genomic features and single-agent response profiles
EP3796903A1 (en) * 2018-05-22 2021-03-31 GBS Global Biopharma, Inc. Cannabinoids and/or terpenes for use in trpv1 modulation
CA3104795A1 (en) * 2018-06-28 2020-01-02 Canopy Growth Corporation Compositions and methods for agonizing the cb2 receptor
US10897925B2 (en) * 2018-07-27 2021-01-26 Joseph Pandolfino Articles and formulations for smoking products and vaporizers
CA3119729A1 (en) 2018-10-10 2020-04-16 Treehouse Biotech, Inc. Synthesis of cannabigerol
WO2020084444A1 (en) * 2018-10-22 2020-04-30 Radient Technologies Innovations Inc. Flavoring process
EP3878440A1 (en) * 2018-11-08 2021-09-15 GBS Global Biopharma, Inc. Therapeutic nanoparticles which encapsulate terpenoids and/or cannabinoids
UY38480A (es) 2018-11-19 2020-06-30 Receptor Holdings Inc Aminoácidos grasos n-acilados para reducir la variabilidad de absorción en composiciones a base de cannabinoides
EP3902538A4 (en) * 2018-12-29 2023-01-18 Buzzelet Development And Technologies Ltd ISOLATED OR SYNTHETIC CANNABINOID COMPOSITIONS WITH SELECTED TERPEN BLEND AND METHODS OF USE THEREOF
US11026881B2 (en) * 2019-01-02 2021-06-08 Daniel S. Nam Sedative laced toothpaste
CA3070689C (en) * 2019-02-11 2021-12-07 Hexo Operations Inc. Methods and systems for industrial processes
NL2022614B1 (en) * 2019-02-21 2020-08-31 Patrick Alexander Unger Pharmaceutical, phyto-cannabinoid based compositions
SG11202111809XA (en) * 2019-04-24 2021-11-29 Inmed Pharmaceuticals Inc Compositions and methods for use of cannabinoids for neuroprotection
US10993928B2 (en) * 2019-04-26 2021-05-04 Natural Extraction Systems, LLC Compositions comprising non-crystalline forms of cannabidiol
MX2021013656A (es) * 2019-05-06 2022-01-06 Univ British Columbia Formulaciones antibioticas de cannabinoides-terpenos.
US20220242809A1 (en) * 2019-07-12 2022-08-04 Atlas Hemp Company Llc. Methods for isolating essential oils, phytochemicals and pharmaceutically active components from biomass and reconstituting synthetic formulations comprising same
WO2021050786A1 (en) * 2019-09-10 2021-03-18 California Amber Inc. Cannabin oid compositions with improved organoleptic and therapeutic properties, method of production, and use thereof
CN114786725A (zh) * 2019-09-18 2022-07-22 药妆研究有限责任公司 含有内源性大麻素模拟物和抗炎化合物的组合物、其制备方法及用途
US11542243B1 (en) 2019-09-26 2023-01-03 FusionFarms, LLC Method of converting delta9-THC to delta10-THC and the purification of the delta10-THC by crystallization
CA3057647A1 (en) * 2019-10-03 2021-04-03 Vinsan Therapeutics Inc. Topical formulations and instillates, kits, and methods for treating integumentary wounds, and uses thereof
WO2021113261A1 (en) * 2019-12-02 2021-06-10 Natural Extraction Systems, LLC Compositions comprising novel cannabinoid and terpene profiles
WO2021127749A1 (en) * 2019-12-24 2021-07-01 Cannadol Pharmaceuticals Ltd Compositions comprising terpenes and their use in the treatment or alleviation of pain or anxiety
US20230165807A1 (en) * 2019-12-30 2023-06-01 Calibrated Therapeutics, Llc Compositions including terpenes, cannabinoid oils, or flavonoids and uses thereof
CA3171615A1 (en) 2020-03-13 2021-09-16 Altopa, Inc. Precision control and characterization of dispensed substances
AU2021264109A1 (en) * 2020-04-29 2022-12-08 Ligar Limited Partnership Imprinted polymers and methods for their use
IL298623A (en) * 2020-05-31 2023-01-01 Buzzelet Development And Technologies Ltd Liquid cannabis compositions and uses thereof
US11524040B2 (en) 2020-08-24 2022-12-13 Charlotte's Web, Inc. Composition for the treatment of acne
US20240108583A1 (en) * 2021-01-25 2024-04-04 LDN Pharma Limited Naltrexone compositions
US12288603B2 (en) 2021-04-09 2025-04-29 Endocanna Health, Inc. Machine-learning based efficacy predictions based on genetic and biometric information
GB202109018D0 (en) * 2021-06-23 2021-08-04 Ldn Pharma Ltd Treatment with an agonist of a 5-hydroxytryptamine (5-ht) receptor
WO2023043826A1 (en) 2021-09-14 2023-03-23 Transport Authority, Inc. Systems and methods for accurate and repeatable delivery of active pharmaceutical ingredients
DK4404774T3 (da) * 2021-09-20 2025-04-07 Opes Corp Oy Aktivt ingredientsleveringssystem
US20250367220A1 (en) * 2022-06-17 2025-12-04 New Growth Brands, Inc. Compositions comprising cannabinoids and methods of preparation and use thereof
US20240316072A1 (en) * 2023-03-21 2024-09-26 Unique Flower LLC Therapeutic compositions, components and methods of preparation and use thereof
WO2024209332A1 (en) * 2023-04-02 2024-10-10 Buzzelet Development And Technologies Ltd. Cannabinoid compositions and products

Family Cites Families (39)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US4837228A (en) 1979-05-31 1989-06-06 The University Of Mississippi Antiinflammatory and antimicrobial compounds and compositions
US5891469A (en) 1997-04-02 1999-04-06 Pharmos Corporation Solid Coprecipitates for enhanced bioavailability of lipophilic substances
US6458373B1 (en) 1997-01-07 2002-10-01 Sonus Pharmaceuticals, Inc. Emulsion vehicle for poorly soluble drugs
US7766013B2 (en) * 2001-06-05 2010-08-03 Alexza Pharmaceuticals, Inc. Aerosol generating method and device
US20030101902A1 (en) * 2001-12-04 2003-06-05 Ann Reitnauer Hot melt inks
MXPA04011808A (es) * 2002-05-31 2005-09-12 Univ Mississippi Liberacion transmucosica de canabinoides.
CN104397869B (zh) 2003-11-07 2016-06-08 美国无烟烟草有限责任公司 烟草组合物
GB0329635D0 (en) 2003-12-23 2004-01-28 Johnson Matthey Plc Process for purifying trans-tetrahydrocannabinol
FR2885619B1 (fr) 2005-05-13 2011-02-11 Imaje Sa Composition d'encre liquide, alimentaire, ingerable pour l'impression par jet d'encre
WO2008024408A2 (en) * 2006-08-22 2008-02-28 Theraquest Biosciences, Inc. Pharmaceutical formulations of cannabinoids for application to the skin and method of use
US7923026B2 (en) 2006-10-20 2011-04-12 Solvay Pharmaceuticals B.V. Embedded micellar nanoparticles
GB2448535A (en) 2007-04-19 2008-10-22 Gw Pharma Ltd New use for cannabinoid-containing plant extracts
US20090098192A1 (en) 2007-10-11 2009-04-16 Fuisz Richard C Extrudable and Extruded Compositions for Delivery of Bioactive Agents, Method of Making Same and Method of Using Same
DE102009019322A1 (de) 2009-04-30 2010-11-11 The Health Concept Gmbh Verfahren zur Herstellung von Synthetischen Cannabinoiden
CA2772634C (en) * 2009-08-31 2017-11-21 Alltranz Inc. Use of cannabidiol prodrugs in topical and transdermal administration with microneedles
GB2478595B (en) * 2010-03-12 2018-04-04 Gw Pharma Ltd Phytocannabinoids in the treatment of glioma
TWI583374B (zh) 2010-03-30 2017-05-21 Ｇｗ伐瑪有限公司 使用植物大麻素次大麻二酚（ｃｂｄｖ）來治療癲癇之用途
WO2011135591A2 (en) * 2010-04-29 2011-11-03 Shasun Pharmaceuticals Limited Novel tablet composition of polyallylamine polymers
GB2494461A (en) * 2011-09-12 2013-03-13 Gw Pharma Ltd Phytocannabinoids for use in the treatment of invasive cancers or metastases
GB2495118B (en) 2011-09-29 2016-05-18 Otsuka Pharma Co Ltd A pharmaceutical composition comprising the phytocannabinoids cannabidivarin (CBDV) and cannabidiol (CBD)
EP2763663B1 (en) 2011-10-06 2017-12-27 Novartis AG Pharmaceutical compositions comprising 40-o-(2-hydroxy)ethyl-rapamycin
US9345771B2 (en) 2012-10-04 2016-05-24 Insys Development Company, Inc. Oral cannabinoid formulations
CA2895805A1 (en) 2012-12-18 2014-06-26 Kotzker Consulting Llc Use of cannabinoids and terpenes for treatment of organophosphate and carbamate toxicity
EP2968259B1 (en) 2013-03-14 2022-09-14 SC Laboratories Inc. Bioactive concentrates and uses thereof
PL3009004T3 (pl) 2013-03-29 2020-03-31 Intercontinental Great Brands Llc Przezroczyste i półprzezroczyste cukierki z płynnym nadzieniem; bezcukrowa, płynna, jadalna kompozycja
US9056049B2 (en) 2013-05-30 2015-06-16 Chin Yuan Huang Micro-particle comprising a protein extract from sweet potato for extending satiety and controlling blood glucose and lipid levels
US9770514B2 (en) 2013-09-03 2017-09-26 ExxPharma Therapeutics LLC Tamper-resistant pharmaceutical dosage forms
ES2616887T3 (es) 2013-10-29 2017-06-14 Echo Pharmaceuticals B.V. Comprimido que contiene delta 9-tetrahidrocannabinol, método para su producción y uso de tal comprimido en el tratamiento oral
US20160279073A1 (en) 2013-10-31 2016-09-29 Full Spectrum Laboratories, Ltd. Terpene and cannabinoid formulations
ES2784229T3 (es) 2013-11-20 2020-09-23 Panag Pharma Inc Composiciones y procedimientos para el tratamiento de la inflamación y el dolor ocular
US20160022627A2 (en) * 2014-04-18 2016-01-28 Mary's Medicinals LLC Transdermal cannabinoid patch
AU2015280412B2 (en) 2014-06-26 2018-07-26 Island Breeze Systems Ca, Llc MDI related products and methods of use
US9861611B2 (en) 2014-09-18 2018-01-09 Virun, Inc. Formulations of water-soluble derivatives of vitamin E and soft gel compositions, concentrates and powders containing same
US9375417B2 (en) * 2014-12-04 2016-06-28 Mary's Medicinals LLC Transdermal cannabinoid formulations
WO2016109624A1 (en) 2014-12-30 2016-07-07 University Of Houston System Pharmaceutical compositions
US20160250270A1 (en) 2015-02-27 2016-09-01 Ebbu, LLC Compositions comprising combinations of purified cannabinoids, with at least one flavonoid, terpene, or mineral
US20170266153A1 (en) 2015-02-27 2017-09-21 Ebbu, LLC Compositions purposefully selected comprising purified cannabinoids and/or purified terpenes
IL246790A0 (en) 2016-07-14 2016-09-29 Friedman Doron Self-dissolving compounds of cannabinoids
US11007170B2 (en) 2017-02-02 2021-05-18 Panaxia Pharmaceutical Industries Ltd. Composition for buccal or sublingual administration of cannabis extract and methods for making same

Also Published As

Publication number Publication date
CA2977802A1 (en) 2016-09-01
US10821147B2 (en) 2020-11-03
US20190030101A1 (en) 2019-01-31
US20160250270A1 (en) 2016-09-01
IL254025A0 (en) 2017-10-31
WO2016138505A1 (en) 2016-09-01
IL254025B (en) 2021-04-29
BR112017018316A2 (pt) 2018-04-17
AU2016225026A1 (en) 2017-09-07

Similar Documents

Publication Publication Date Title
IL254025A0 (en) Compositions containing a mixture of pure cannabinoids with at least one flavonoid, terpene or mineral
BR112017018276A2 (pt) ?composição que compreende peptidase e biotensoativo e seu uso?
EP3429580A4 (en) TERPENANGED CANNABINOID COMPOSITION
MX379270B (es) Composiciones que comprenden cepas bacterianas.
CL2016002772A1 (es) Composiciones de insulina de rápida acción
MX2018003696A (es) Composicion acida que comprende una ficocianina.
MX385749B (es) Composiciones que comprenden una caseína y métodos para producir las mismas.
AR100498A1 (es) Mejora en la reducción de la fricción
BR112017021665A2 (pt) composições de conservantes sinérgicos.
BR112016020199A2 (pt) Composto inibidor de calicreína plasmática de humano, composição farmacêutica compreendendo o referido composto, kit e seu uso
EP3442521B1 (en) Sweeteners and other compositions infused with cannabis
BR112017005507A2 (pt) composições que compreendem células recombinantes de bacillus e um fungicida.
BR112017005379A2 (pt) composições que compreendem células recombinantes de bacillus e um fungicida.
BR112017018420A2 (pt) composição curável
BR112017021126A2 (pt) composição de lignina ativada, método para a sua produção e utilização
PH12015502014A1 (en) Racecadotril lipid compositions
CO2017010091A2 (es) Composiciones tópicas que comprenden un corticosteroide
MX2017001490A (es) Combinaciones de farmacos para tratar mieloma multiple.
MX2015018028A (es) Composiciones de lagrimas artificiales.
MX2017012553A (es) Compuestos espirociclicos.
BR112017022691A2 (pt) inibidor de bromodomínio.
EP3261629A4 (en) Compositions comprising combinations of purified cannabinoids, with at least one flavonoid, terpene, or mineral
BR112018077458A2 (pt) proteases aspárticas
DK3582796T3 (da) Sammensætning mod hoste
CL2018000308A1 (es) Composiciones en microcápsulas que comprenden pirimetanilo